Xuechen Chen

1.0k total citations · 2 hit papers
20 papers, 518 citations indexed

About

Xuechen Chen is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Xuechen Chen has authored 20 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 4 papers in Genetics. Recurrent topics in Xuechen Chen's work include Colorectal Cancer Screening and Detection (14 papers), Genetic factors in colorectal cancer (8 papers) and Genetic Associations and Epidemiology (4 papers). Xuechen Chen is often cited by papers focused on Colorectal Cancer Screening and Detection (14 papers), Genetic factors in colorectal cancer (8 papers) and Genetic Associations and Epidemiology (4 papers). Xuechen Chen collaborates with scholars based in Germany, China and Australia. Xuechen Chen's co-authors include Michael Hoffmeister, Hermann Brenner, Daniel Boakye, Jenny Chang‐Claude, Feng Guo, Wenhua Ling, Xu Chen, Yan Yang, Hongliang Xue and Chen Shen and has published in prestigious journals such as Gastroenterology, Circulation Research and International Journal of Cancer.

In The Last Decade

Xuechen Chen

20 papers receiving 514 citations

Hit Papers

Gut Microbially Produced Indole-3-Propionic Acid Inhibits... 2022 2026 2023 2024 2022 2025 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuechen Chen Germany 11 216 175 123 111 78 20 518
Sung-Eun Kim South Korea 4 237 1.1× 118 0.7× 92 0.7× 108 1.0× 89 1.1× 9 502
Hiroko Koga Japan 9 137 0.6× 106 0.6× 69 0.6× 68 0.6× 49 0.6× 10 343
Tetsuo Kuroishi Japan 8 245 1.1× 98 0.6× 59 0.5× 110 1.0× 35 0.4× 9 483
Nobutoshi Imaizumi Japan 11 118 0.5× 116 0.7× 63 0.5× 144 1.3× 24 0.3× 14 484
R.J. Bryant United States 9 228 1.1× 208 1.2× 70 0.6× 126 1.1× 28 0.4× 15 589
Keiichiro Genka Japan 12 183 0.8× 164 0.9× 31 0.3× 111 1.0× 121 1.6× 24 529
Paulo Traiman Brazil 14 124 0.6× 59 0.3× 52 0.4× 162 1.5× 32 0.4× 46 606
Helen G. Mulholland United Kingdom 7 117 0.5× 75 0.4× 75 0.6× 39 0.4× 23 0.3× 10 327
Y-T Gao United States 7 142 0.7× 89 0.5× 27 0.2× 170 1.5× 36 0.5× 8 383
Muhammad Talal Sarmini United States 8 181 0.8× 142 0.8× 34 0.3× 55 0.5× 102 1.3× 29 473

Countries citing papers authored by Xuechen Chen

Since Specialization
Citations

This map shows the geographic impact of Xuechen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuechen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuechen Chen more than expected).

Fields of papers citing papers by Xuechen Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuechen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuechen Chen. The network helps show where Xuechen Chen may publish in the future.

Co-authorship network of co-authors of Xuechen Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xuechen Chen. A scholar is included among the top collaborators of Xuechen Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuechen Chen. Xuechen Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Zihao, Rong Li, Lukman O. Afolabi, et al.. (2025). MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy. Cancer Gene Therapy. 32(4). 371–392. 23 indexed citations breakdown →
3.
Chen, Xuechen, et al.. (2024). Excess Weight, Polygenic Risk Score, and Findings of Colorectal Neoplasms at Screening Colonoscopy. The American Journal of Gastroenterology. 119(9). 1913–1920. 2 indexed citations
4.
Chen, Xuechen, et al.. (2023). Associations of smoking with early- and late-onset colorectal cancer. JNCI Cancer Spectrum. 7(1). 16 indexed citations
5.
Chen, Xuechen, Thomas Heisser, Rafael Cardoso, Michael Hoffmeister, & Hermann Brenner. (2023). Overall and age‐specific risk advancement periods of colorectal cancer for men vs women: Implications for gender‐sensitive screening offers?. International Journal of Cancer. 153(3). 547–551. 4 indexed citations
6.
Chen, Xuechen, Thomas Heisser, Rafael Cardoso, Michael Hoffmeister, & Hermann Brenner. (2023). Personalized Initial Screening Age for Colorectal Cancer in Individuals at Average Risk. JAMA Network Open. 6(10). e2339670–e2339670. 5 indexed citations
7.
Xue, Hongliang, Xu Chen, Chao Yu, et al.. (2022). Gut Microbially Produced Indole-3-Propionic Acid Inhibits Atherosclerosis by Promoting Reverse Cholesterol Transport and Its Deficiency Is Causally Related to Atherosclerotic Cardiovascular Disease. Circulation Research. 131(5). 404–420. 150 indexed citations breakdown →
8.
Chen, Xuechen, et al.. (2022). The power of a healthy lifestyle for cancer prevention: the example of colorectal cancer. Cancer Biology and Medicine. 19(11). 1586–1597. 12 indexed citations
9.
Chen, Xuechen, et al.. (2022). Alcohol consumption, polygenic risk score, and early- and late-onset colorectal cancer risk. EClinicalMedicine. 49. 101460–101460. 34 indexed citations
10.
Chen, Xuechen, et al.. (2022). Assessment of Body Mass Index, Polygenic Risk Score, and Development of Colorectal Cancer. JAMA Network Open. 5(12). e2248447–e2248447. 10 indexed citations
11.
Chen, Xuechen, Feng Guo, Jenny Chang‐Claude, Michael Hoffmeister, & Hermann Brenner. (2022). Physical activity, polygenic risk score, and colorectal cancer risk. Cancer Medicine. 12(4). 4655–4666. 7 indexed citations
12.
Guo, Feng, Dominic Edelmann, Rafael Cardoso, et al.. (2022). Polygenic Risk Score for Defining Personalized Surveillance Intervals After Adenoma Detection and Removal at Colonoscopy. Clinical Gastroenterology and Hepatology. 21(1). 210–219.e11. 8 indexed citations
13.
Chen, Xuechen, Michael Hoffmeister, & Hermann Brenner. (2022). Red and Processed Meat Intake, Polygenic Risk Score, and Colorectal Cancer Risk. Nutrients. 14(5). 1077–1077. 10 indexed citations
14.
Boakye, Daniel, Xuechen Chen, Lina Jansen, et al.. (2021). Associations of Body Mass Index at Different Ages With Early-Onset Colorectal Cancer. Gastroenterology. 162(4). 1088–1097.e3. 65 indexed citations
15.
Boakye, Daniel, et al.. (2021). Association of Body Mass Index With Risk of Early-Onset Colorectal Cancer: Systematic Review and Meta-Analysis. The American Journal of Gastroenterology. 116(11). 2173–2183. 76 indexed citations
16.
Chen, Xuechen, Lina Jansen, Feng Guo, et al.. (2021). Smoking, Genetic Predisposition, and Colorectal Cancer Risk. Clinical and Translational Gastroenterology. 12(3). e00317–e00317. 23 indexed citations
17.
Guo, Feng, Xuechen Chen, Jenny Chang‐Claude, Michael Hoffmeister, & Hermann Brenner. (2021). Colorectal Cancer Risk by Genetic Variants in Populations With and Without Colonoscopy History. JNCI Cancer Spectrum. 5(1). 3 indexed citations
18.
Chen, Xuechen, Feng Guo, Michael Hoffmeister, Jenny Chang‐Claude, & Hermann Brenner. (2021). Non‐steroidal anti‐inflammatory drugs, polygenic risk score and colorectal cancer risk. Alimentary Pharmacology & Therapeutics. 54(2). 167–175. 16 indexed citations
20.
Chen, Yanwei, et al.. (2019). <p>Oral Microbiota as Promising Diagnostic Biomarkers for Gastrointestinal Cancer: A Systematic Review</p>. OncoTargets and Therapy. Volume 12. 11131–11144. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026